| Long name: |
EDA2R Primary Polyclonal Antibody |
| Also known as: |
EDA2R PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
EDA2R |
| Specificity: |
This is a highly specific antibody against EDA2R |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Immunogen range: |
80-138/297 |
| Subcellular location: |
Extracellular |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human EDA2R/TNFRSF27 |
| Gene ID number: |
60401 |
| Swiss Prot: |
Q9HAV5 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
Activation seems to be mediated by binding to TRAF3 and TRAF6, Mediates the activation of the NF-kappa-B and JNK pathways, but not for EDA isoform A1, Receptor for EDA isoform A2 |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
EDA-A2 receptor, EDA-A2R, EDA2R, EDAA2R, TNFRSF27, Tumor necrosis factor receptor superfamily member 27, UNQ2448/PRO5727/PRO34080, X-linked ectodysplasin-A2 receptor, XEDAR |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
EDA2R |
| Short name: |
EDA2R Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
ectodysplasin A2 receptor (Antibody to) |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
EDA2R and IDBG-636425 and ENSBTAG00000047326 and 100301324, EDA2R and IDBG-73673 and ENSG00000131080 and 60401, Eda2r and IDBG-161374 and ENSMUSG00000034457 and 245527, Plasma membranes, protein binding, this GO :0004872 and receptor activity and molecular function this GO :0005031 and tumor necrosis factor-activated receptor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005887 and integral component of plasma membrane and cellular component this GO :0008544 and epidermis development and biological process this GO :0009790 and embryo development and biological process this GO :0016021 and integral component of membrane and cellular component this GO :0030154 and cell differentiation and biological process this GO :0033209 and tumor necrosis factor-mediated signaling pathway and biological process this GO :0046330 and positive regulation of JNK cascade and biological process this GO :0051092 and positive regulation of NF-kappaB transcription factor activity and biological process this GO :0072332 and intrinsic apoptotic signaling pathway by p53 class mediator and biological process, this GO :0004872 : receptor activity, this GO :0004872 : receptor activity and also this GO :0005031 : tumor necrosis factor-activated receptor activity and also this GO :0005515 : protein binding, this GO :0005031 : tumor necrosis factor-activated receptor activity, this GO :0005515 : protein binding, ectodysplasin A2 receptor |
| Identity: |
17756 |
| Gene: |
EDA2R |
More about : EDA2R |
| Long gene name: |
ectodysplasin A2 receptor |
| Synonyms: |
XEDAR EDA-A2R EDAA2R TNFRSF27 |
| Locus: |
Xq12 |
| Discovery year: |
2004-08-17 |
| GenBank acession: |
AF298812 |
| Entrez gene record: |
60401 |
| Pubmed identfication: |
11039935 |
| RefSeq identity: |
NM_021783 |
| Classification: |
Tumor necrosis factor receptor superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000021736 |
| Locus Specific Databases: |
Mental Retardation database |